Entropy Analysis and Complex Patient-ventilator Interactions During Mechanical Ventilation

NCT ID: NCT04128124

Last Updated: 2020-07-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

107 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-09-01

Study Completion Date

2019-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Complex patterns of patient-ventilator interactions could be miscalculated by visual observation of mechanical ventilator screens or current algorithms based on physiologic waveforms to detect patient-ventilator asynchronies. Therefore, we aim to characterize, validate and study the clinical distribution and implications of an automated and personalized non-invasive tool based on Entropy to detect Complex Patient-Ventilator Interactions (CP-VI) during mechanical ventilation, defined as breathing pattern change and/or clusters of asynchronies, over the signals of airway pressure (Paw) and airway flow (Flow).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Methods

1. Defining complex patient ventilator interactions The Investigators defined "Complex Patient-Ventilator Interactions" (CP-VI) as the presence alone or in combination of a change in the respiratory rate of more than 50%, and/or the occurrence of any kind of asynchronies
2. Data acquisition and data analysis Paw and Flow signals will continuously recorded throughout patient's stay in the Intensive Care Unit (UCI) using BetterCare® system (Better Care®, Barcelona, Spain). BetterCare uses drivers specifically designed to interact with the output signal of mechanical ventilators and bedside monitors rather than directly with patients. Recorded signals are synchronized and stored for further analysis. MATLAB (The MathWorks, Inc., vR2018b, Natick, MA, USA) will be used to perform the signal processing, data analysis and visual assessment.
3. Study Population The Investigators will obtain data from an prospectively constructed database from a connectivity platform (Better Care®) to interoperate signals from different ventilators and monitors and subsequently compute algorithms to diagnose patient-ventilator asynchronies (ClinicalTrial.gov, NCT03451461). All of those patients corresponding to a self-extubation event previously recorded will be recruited for the characterization and validation process, in order to guarantee at patient-ventilator interactions and episodes when they fight the ventilator. Also, patients in whom an spontaneous breathing trial previous to an attempt to librate him/her from the ventilator will be recruited in order to obtain signals of Paw and Flow. Clinical and demographic data will obtained from the medical chart. The institutional review board approved the protocol and waived informed consent because the study was non-interventional, posed no added risk to patients, and did not interfere with usual care.
4. Visual validation of CP-VI Three researchers will visually review the Flow and Paw recordings of events. The segments duration will selected based on previous studies where asynchronous clusters are evaluated. The dataset will be previously selected by an expert in mechanical ventilation ensuring balance by ventilation modes (grouped by Pressure Support Ventilation (PSV) and Assist-Control Ventilation modes) and equal distribution of CP-VI presence or absence. The controlled modes included volume assist-control ventilation (VACV) and pressure assist-control ventilation (PACV). Flow and Paw tracings will be randomly ordered in MATLAB prior to visual analysis to ensure blinding of the scorers. Scorers will be provided with written description of CP-VI characteristics before visual analysis, as a reference. On base of CP-VI definition previously described, each researcher will score for the presence or absence of CP-VI events, without time limitation. The visual assessment will considered as the gold standard.
5. Entropy Entropy is a non-linear measure that allows assessing the randomness of a series of data. Entropy calculation requires three parameters: the embedding dimension, m (a positive integer); the tolerance value or similarity criterion, r (a positive real number); and the total length, N, of the analysed series.
6. Automatic CP-VI detection An automated algorithm for CP-VI detection based on Entropy tool will be implemented.
7. Statistical analysis Fleiss's kappa coefficient will be used as reliability of agreement among raters for visual assessment. The automated algorithm for CP-VI detection will be applied over the entropy series derived from the same Flow and Paw. The performance of the automated algorithm will be evaluated on base of sensitivity (Se), specificity (Sp), positive and negative predictive values (PPV and NPV, respectively), accuracy (ACC) and Matthews correlation coefficient (MCC).
8. Selection of m, r and N In entropy studies, an important step is to determine the optimal settings to robust extract the randomness of a series of data. Therefore, an optimization procedure of m, r and N will performed to properly estimate CP-VI.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patient Ventilator Interactions Spontaneous Breathing Trial

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

self-extubation

patients receiving invasive mechanical ventilation who develops an episode of self-removal (voluntary) of the endotracheal tube. Excluding those accidentally removed.

processing signals of airway pressure and airway flow to calculate entropy

Intervention Type OTHER

processing of previously recorded data from a dedicated software of airway pressure and airway flow in order to calculate entropy

spontaneous breathing trial

patients who, according to the attending physician, are clinically ready to initiate and begin a protocolized test (acording to the institutions or unit) to evaluate the readiness to be liberated from mechanical ventilation.

processing signals of airway pressure and airway flow to calculate entropy

Intervention Type OTHER

processing of previously recorded data from a dedicated software of airway pressure and airway flow in order to calculate entropy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

processing signals of airway pressure and airway flow to calculate entropy

processing of previously recorded data from a dedicated software of airway pressure and airway flow in order to calculate entropy

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Admission to a ICU bed equipped with BetterCare software and intubated fo mechanical ventilation expected to last more than 24hs
* patients who develops a self-extubation episode or a spontaneous breathing trial.

Exclusion Criteria

* \<18 years
* \<48hs of recorded data
* moribund state
* admission for organ donation
* chest tubes with suspected bronchopleural fistula
* accidental extubation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Corporacion Parc Tauli

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Candelaria de Haro

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lluis Blanch, M.D., Ph.D.

Role: STUDY_DIRECTOR

Critical Care Center, Hospital Universitari Parc Tauli. Institut d'Investigació i Innovació Parc Taulí.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Universitari Parc Taulí

Sabadell, Barcelona, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Tauli entropy-ICU

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.